AstraZeneca's blockbuster breast cancer drug will be added to China's national reimbursement scheme list, according to an ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

The three largest pharmacy benefit managers — or PBMs — earlier this month went to court to quash a suit by the Federal Trade ...

Endometriosis sufferers will have access to a new affordable treatment for the first time in 30 years.

Akeso, Inc. (9926. HK) ('Akeso' or the 'Company') is pleased to announce that two of its independently developed, globally ...

President-elect Donald Trump's spin on his nomination of Pam Bondi as attorney general is notably different from the way he ...

An anxiety drug is being voluntarily recalled over a mislabeling error that could be “possibly life-threatening," according ...

AstraZeneca's (NASDAQ:AZN) blockbuster cancer medication, Enhertu, developed with Japanese pharma giant Daiichi Sankyo (OTCPK ...

A new bill has been introduced by lawmakers, including two in Virginia, to address drug shortages in the U.S. The End Drug ...

Included in National Reimbursement Drug List (NRDL) - Significantly Boosting market Penetration and Driving Valuation Reassessment . HONG KONG, N ...

Limited (HK:0013) has released an update. HUTCHMED (China) Limited has announced that its cancer drug ORPATHYS®, designed for ...